All lobbying filings

JAZZ PHARMACEUTICALS, INC.

Lobbying for JAZZ PHARMACEUTICALS, INC.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $470,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 1

HR 946
ORPHAN Cures Act

Lobbying activity 1

Pharmacy

FDA regulation of CBD FDA Rare Disease PPRV program/reauthorization Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Most Favored Nation drug pricing Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act HR 946: Orphan Cures Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.